A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy
John A. Glaspy(University of California, Los Angeles), Alan Colowick(Amgen (United States)), James R. Rigas(Dartmouth–Hitchcock Medical Center), J. Jadeja(Hematology Oncology Associates), David J. Kuter(Harvard University), George D. Demetri(American Society of Clinical Oncology), Debra M. Prow(Cancer Care Services), J O’Byrne(Amgen (United States)), Derek Richards, Lee S. Schwartzberg(Renown Health), Alan Saven(Scripps Research Institute), David Gordon(Massachusetts General Hospital), James C. Arseneau(Regional Cancer Center), J. Keßler(Virginia Oncology Associates), Harry E. Hynes, Glen R. Justice(Orange Coast Memorial Medical Center), Ralph V. Boccia(Center for Cancer and Blood Disorders), David C. Harmon(Massachusetts General Hospital)
Cited by 81
Related Papers
Power Spectrum Analysis of Heart Rate Fluctuation: A Quantitative Probe of Beat-to-Beat Cardiovascular Control
|Science|1981|5.1k
Assessment of autonomic function in humans by heart rate spectral analysis
|American Journal of Physiology-Heart and Circulatory Physiology|1985|2.9k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
|Blood Advances|2019|1.1k
Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor
|New England Journal of Medicine|2010|871